Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

4 Results Found

FDA approves first-in-class non-opioid painkiller 

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.

AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America

In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities and how an opioid risk tool provides guidance and protocols to protect higher-risk patients.

AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities 

Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to meet the behavioral health needs of its communities.

AHA hosts webinar on opioid stewardship best practices

Opioid-related deaths rose in the last year, intensifying the need for effective opioid stewardship programs.